| INFORMATION
All submissions will only be accepted through EM®. Please note that we cannot accept direct submissions to the editorial office
email. If you plan to submit, you will need to register a new ID and password. Please check our Privacy Policy when registering. The revised guidelines will apply from Volume 30 (April
2026).
Manuscripts submitted to our journal must be original scholarly works that contribute to advancement of the human services field. Submissions must not have been previously published or under
consideration for publication elsewhere, including in academic journals, commercial publications, institutional repositories, or any other scholarly outlets. This restriction, however, does not
extend to preliminary research outputs such as proceedings or reports submitted by funding agencies.
- Authors are expected to be aware of, and comply with, best practices in publication ethics, including but not limited to those pertaining to authorship (for example, avoidance of ghost or
guest authorship), duplicate submission/publication, attribution, plagiarism, and competing interests.
- Reviewers and editors are required to treat manuscripts fairly and in confidence and to declare any competing interests.
- Research involving human subjects must adhere to the Helsinki Declaration and, where applicable, be reviewed by an institutional ethics committee or its
equivalent. Personal information must be anonymized; it full anonymization is not feasible, informed consent for publication and associated risks must be obtained.
All co-authors must take responsibility for the content of the manuscript. In addition, all co-authors are expected to have made substantial contributions to the submitted work and to be
accountable for the work both before and after publication. The following criteria should be satisfied.
- All co-authors, including the corresponding author, have made substantial contributions to one or more of the following: conception or design of the study; acquisition, (statistical)
analysis, or interpretation of the data; creation of any software used in the study; and drafting or substantially revising the article.
- All co-authors, including the corresponding author, have approved the submission (and any substantially revised version that includes the authors' contributions to the study).
- All co-authors, including the corresponding author, have agreed to be personally responsible for their own contributions and to ensure that any questions regarding the accuracy or
completeness of any part of the work are appropriately investigated and resolved and that the resolution is documented in the literature.
The category of published articles in our journal shall be based on the following criteria.
- "ORIGINAL ARTICLE" is a study report that is original and has clear conclusions.
- "REVIEW ARTICLE" is a study report that summarizes prior research on a particular field or topic.
- "SHORT PAPER" refers to research reports that are original and require prompt publication.
- "CASE REPORT" is an interesting case report that is highly suggestive to readers.
All manuscripts will be accepted exclusively through our peer-reviewed submission system, Editorial Manager®.
The copyright of articles is retained by the authors. The authors grant Asian Society of Human Services (ASHS) an unlimited license to publish the article under a Creative Commons License (CC
BY-NC-ND) and identify ASHS as the original publisher. Submission of an article for publication implies the authors' consent to publication under the applicable Creative Commons License and the
terms and conditions of the Publisher's Licensing Agreement.
All articles are published as open access on the official website, J-STAGE, and Scopus.
Author requests for text revisions will not be accepted after the manuscript has been fully published on the website and in all academic databases. However, if serious errors or legal problems
are discovered after the article has been published, authors must promptly notify the editorial office. For more information on examples of serious errors, please refer to the "Allegations of
Misconduct" in
the Publication Ethics and Publication Malpractice Statement.
Any commercial interests that may present a potential conflict of interest -such as consultancy fees, research funding, share ownership, or patent holdings- must be fully disclosed.
All manuscripts must be checked by a native English speaker, and this should be clearly stated at the time of submission.
The Article-Processing Charge (APC) for our journal will be invoiced after the manuscript is accepted, and publication is considered confirmed once payment has been confirmed.
The manuscript received in each submission category shall adhere to the specifications outlined below. Submissions that do not comply with the prescribed format will not be considered for review.
Enforced on December 1, 2013
Revised on September 7, 2025
Submissions to our journal may fall into the following categories.
We recommend that the "Original Article" follow the format below, but this is not a mandatory requirement.
- When citing references within the text, the corresponding reference number should be indicated using superscript numerals enclosed in parentheses.
- When citing multiple references, separate each number with a comma. If citing a consecutive range of references, use a hyphen to indicate the range.
e.g.)
This sentence was written by editor of Asian Journal of Human Services 1).
This sentence was written by editor of Asian Journal of Human Services 1,3,7).
This sentence was written by editor of Asian Journal of Human Services 1-3).
- When referring to a specific author's report in the text, include the publication year.
e.g.) 1 person:
Smith (2025) reported that further research is needed 1).
e.g.) 2 or more:
Smith et al. (2025) reported that further research is needed 1).
- When referring to a specific device, the name should be presented in the following format: Generic name (manufacturer, product name)
e.g.) blood pressure monitor (Omron, HEM-8712)
- When referring to a pharmaceutical product, the product name should be presented in the following format: generic name (trade name ®).
e.g.) acetaminophen (Tylenol ®)
Enforced on December 1, 2013
Revised on September 7, 2025